Burundanga: mito o realidad por conocer / Burundanga: a myth or reality still to be learned

No disponible

Orally ingestion of krokodil in Spain: report of a case. / Consumo de krokodil por vía oral en España: a propósito de un caso.

The krokodil use disorder is an addictive pathology with quite severe organic effects, especially at the skin level, that causes severe and degenerative necrosis of blood and muscle tissue. Though this disorder has a low prevalence in Spain, compared to the large number of consumers in other countries such as Ukraine or Russia, its consumption is slowly but gradually expanding in countries of the European Union and America. The simplicity of the process of obtaining the substance from desomorphine, together with its high availability and low cost, contribute toward consumers' self-sufficiency. This article presents the case of a user of krokodil and reviews the clinical symptoms of oral ingestion.

El trastorno por uso de krokodil es una de las patologías adictivas con mayores repercusiones orgánicas, principalmente a nivel cutáneo, produciendo una grave y degenerativa necrosis del tejido sanguíneo y muscular. Se trata de un trastorno con escasa prevalencia en España, frente al elevado número de consumidores en otros países como Ucrania o Rusia, si bien se está produciendo una lenta aunque gradual expansión del consumo en países de la Unión Europea y del continente americano. El sencillo proceso de obtención de la sustancia desde la desomorfina, unido a la elevada disponibilidad y bajo coste, configura el proceso de autoabastecimiento de los consumidores. En este artículo revisamos un cuadro clínico, presentando el caso de un paciente que consume krokodil por vía oral.

Consumo de krokodil por vía oral en España: a propósito de un caso / Orally ingestion of krokodil in Spain: report of a case

El trastorno por uso de krokodil es una de las patologías adictivas con mayores repercusiones orgánicas, principalmente a nivel cutáneo, produciendo una grave y degenerativa necrosis del tejido sanguíneo y muscular. Se trata de un trastorno con escasa prevalencia en España, frente al elevado número de consumidores en otros países como Ucrania o Rusia, si bien se está produciendo una lenta aunque gradual expansión del consumo en países de la Unión Europea y del continente americano. El sencillo proceso de obtención de la sustancia desde la desomorfina, unido a la elevada disponibilidad y bajo coste, configura el proceso de autoabastecimiento de los consumidores. En este artículo revisamos un cuadro clínico, presentando el caso de un paciente que consume krokodil por vía oral

The krokodil use disorder is an addictive pathology with quite severe organic effects, especially at the skin level, that causes severe and degenerative necrosis of blood and muscle tissue. Though this disorder has a low prevalence in Spain, compared to the large number of consumers in other countries such as Ukraine or Russia, its consumption is slowly but gradually expanding in countries of the European Union and America. The simplicity of the process of obtaining the substance from desomorphine, together with its high availability and low cost, contribute toward consumers’ self-sufficiency. This article presents the case of a user of krokodil and reviews the clinical symptoms of oral ingestion

Ansiedad, depresión y autoestima en población general, transeúntes y consumidores de sustancias adictivas / Anxiety, depression and self-esteem in homeless, general population, and substance users

Los trastornos por uso de sustancias coexisten en algunos pacientes con diferentes manifestaciones clínicas de ansiedad y del estado de ánimo, a su vez variables como la autoestima guardan una estrecha relación en el curso y evolución de éstos. En el presente estudio se investiga los trastornos por consumo de sustancias, el transeuntismo y los niveles de ansiedad, depresión y autoestima. La investigación se desarrolla en la ciudad de Castellón con un total de 258 sujetos, divididos en un grupo clínico subdividido en consumidores de cocaína, heroína, heroína combinada con cocaína, cannabis, alcohol y sujetos en programa de mantenimiento con metadona (PMM), un grupo de población general y otro grupo de transeúntes, evaluados mediante el cuestionario STAI, BDI, RSES y una entrevista que recoge aspectos biopsicosociales y clínicos. Los resultados mostraron una mayor gravedad clínica en depresión y ansiedad rasgo en consumidores de heroína inhalada, así como una mayor ansiedad estado y menor autoestima en el grupo de transeúntes. Se puede desprender de los resultados que el consumo de sustancias correlaciona con mayores niveles de ansiedad rasgo y depresión, así como la exclusión social con una menor percepción de autoestima y mayor ansiedad estado

Substance use disorders coexist in some patients with different clinical manifestations of anxiety and mood, in turn variables as self-esteem keep a narrow relation in the course and evolution of these. The present study investigates the relationship between the substance use disorders, the homelessness and the levels of anxiety, depression and self-esteem. Research is carried out in the city of Castellón, with a total of 258 subjects, divided into a clinical group subdivided into cocaine, heroin, heroin combined with cocaine, cannabis, alcohol users and patients in methadone maintenance program (MMP), an general population group and a group of homeless, evaluated through the questionnaire STAI, BDI, RSES and an interview that gathers biopsychosocial and clinical aspects. Results showed a more severe clinical depression and trait anxiety in consumers of inhaled heroin, as well as increased state anxiety and lower self-esteem in the group of homeless. It can be inferred from the results that the substance use correlates with higher levels of trait anxiety and depression and social exclusion with a lower perception of self-esteem and increased anxiety state

The importance of socio-legal interventions in the case management of a severe dual pathology program: our 6 years’ experience

Interest in studying dual diagnosis comorbidity between mental disorders and addictions is increasing, but so far has focused only on epidemiological, clinical and prognostic aspects (Szerman et al, 2013). However, the socio-legal needs of these patients must also be assessed, especially if we are to address the problem using a holistic case management approach, as in the case of other serious mental disorders such as schizophrenia (Nordén, Eriksson, Kjellgren & Norlander, 2012). The Severe Dual Pathology Program (SDPP) at the Provincial Hospital of Castellón Consortium (Spain) began in 2008 and so far has treated 293 patients. The intervention model is integrated, both medically and socially and is based on case management; the inclusion criteria is a score of under 30 on the Global Assessment of Functioning (GAF) scale at admission which must have improved to over 50 for the patient to be discharged. 81.2 % of the patients we have treated so far were male, and most referrals were made from the Emergency Mental Health Unit (32.4 %), followed by the Unit of Addictive Behavior (23.5 %), and the Mental Health Units (15 %). The most prevalent diagnosis at the time of starting the program was schizophrenia (46.8 %), followed by personality disorder (11.3 %), schizoaffective disorder (8.5 %), and bipolar disorder (7.5 %). The majority of patients were polydrug addicts (49.5 %) or addicted to alcohol (27.9 %)